Clinical Trials Directory

Trials / Completed

CompletedNCT02139930

Project 2: Strategies for Reducing Nicotine Content in Cigarettes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,250 (estimated)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main goal of this project is to compare two different approaches to reducing levels of nicotine in cigarettes: an immediate reduction in nicotine content in cigarettes to non-addictive levels or a gradual reduction in nicotine content in cigarettes to non-addictive levels. These two approaches will then be contrasted to a group that continues to smoke cigarettes with nicotine content similar to conventional cigarettes.

Detailed description

This project will be conducted to compare product use patterns and biomarkers of exposure between smokers who are assigned to a) gradual reduction in reduced nicotine content (RNC) cigarettes; b) immediate reduction to very low nicotine content (VLNC) cigarettes or c) normal nicotine content (NNC) cigarettes. The outcomes from this study will provide information on different approaches to reducing levels of nicotine in cigarettes and will determine the approach with the most optimal outcomes taking into account the balance between overall risk reduction (possibly maximized by abrupt switching) and compliance and acceptability (possibly maximized by gradual reduction of RNC cigarettes).

Conditions

Interventions

TypeNameDescription
BEHAVIORALNormal Nicotine Control GroupParticipants will smoke experimental cigarettes for a period of 20-weeks.
BEHAVIORALImmediate Nicotine Reduction GroupParticipants will smoke experimental cigarettes for a period of 20-weeks.
BEHAVIORALGradual Nicotine Reduction GroupParticipants will smoke experimental cigarettes for a period of 20-weeks.

Timeline

Start date
2014-09-01
Primary completion
2017-03-01
Completion
2017-03-14
First posted
2014-05-16
Last updated
2018-08-15

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02139930. Inclusion in this directory is not an endorsement.